Literature DB >> 23820107

Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma.

Dong Hwan Lee1, Jong-Lyel Roh, Seunghee Baek, Jae Hoon Jung, Seung-Ho Choi, Soon Yuhl Nam, Sang Yoon Kim.   

Abstract

OBJECTIVE: Second primary malignancies (SPMs) are common in patients with head and neck squamous cell carcinoma (HNSCC) and have a negative impact on their survival. This study aimed to evaluate risk factors for SPM occurrence and cause-specific mortality in Asian HNSCC patients. STUDY
DESIGN: A retrospective cohort study.
SETTING: University teaching hospital.
SUBJECTS: Nine hundred and thirty-seven patients without previous cancer history who were treated between 2000 and 2009 and followed for at least 2 years.
METHODS: Confirmation of SPMs was performed by histopathology. The cumulative probability of a SPM among survivors of index HNSCC was calculated using a competing risk model. Univariate and multivariate analyses were utilized to determine factors predictive of SPM occurrence and cause-specific mortality.
RESULTS: Of 937 patients, cumulative incidence of SPMs was 7.2% at 0 to 6 months (synchronous), 17.9% at 5 years, and 23.1% at 10 years after index tumor diagnosis. In multivariate analyses, old age (>60 years) (P = .002), hypopharyngeal index tumor site (P = .001), and heavy drinker (P = .001) were independently associated with the development of SPMs, and hypopharyngeal index tumor site were independent variables for SPM-specific survival (P < .001). Cumulative incidence function of SPM-specific mortality according to index tumor sites was significantly higher in the hypopharynx than other sites (P = .011).
CONCLUSION: Elderly patients, hypopharyngeal index cancer patients, or heavy drinkers may require careful surveillance for the development of SPMs. Our results may help identify and properly manage Asian patients at high risk of SPMs.

Entities:  

Keywords:  cumulative incidence; head and neck squamous cell carcinoma; risk factor; second primary malignancy; survival

Mesh:

Year:  2013        PMID: 23820107     DOI: 10.1177/0194599813496373

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  26 in total

1.  Documentation and incidence of late effects and screening recommendations for adolescent and young adult head and neck cancer survivors treated with radiotherapy.

Authors:  Sarah Nicole Hamilton; Omair Arshad; Jaime Kwok; Eric Tran; A Fuchsia Howard; Isabel Serrano; Karen Goddard
Journal:  Support Care Cancer       Date:  2018-11-22       Impact factor: 3.603

2.  Reirradiation with IMRT for recurrent head and neck cancer: A single-institutional report on disease control, survival, and toxicity.

Authors:  Parveen Ahlawat; Sheh Rawat; Anjali Kakria; Bharti Devnani; Inderjit Kaur Wahi; David K Simson
Journal:  Rep Pract Oncol Radiother       Date:  2017-06-07

3.  Clinical and Prognostic Analysis of Hypopharyngeal Squamous Cell Carcinoma with Synchronous and Metachronous Multiple Malignancies.

Authors:  Keisuke Yamamoto; Kenichi Takano; Atsushi Kondo; Makoto Kurose; Kazufumi Obata; Tetsuo Himi
Journal:  In Vivo       Date:  2018 Jan-Feb       Impact factor: 2.155

4.  Time-varying survival effects for squamous cell carcinomas at oropharyngeal and nonoropharyngeal head and neck sites in the United States, 1973-2015.

Authors:  Andrew F Brouwer; Kevin He; Steven B Chinn; Alison M Mondul; Christina H Chapman; Marc D Ryser; Mousumi Banerjee; Marisa C Eisenberg; Rafael Meza; Jeremy M G Taylor
Journal:  Cancer       Date:  2020-09-05       Impact factor: 6.860

5.  Predictors of post-treatment smoking and drinking behavior of head and neck cancer survivors: results of a population-based survey.

Authors:  Ulrike Schiller; Johanna Inhestern; Ulrike Burger; Susanne Singer; Orlando Guntinas-Lichius
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-13       Impact factor: 2.503

Review 6.  Are Survival Outcomes Different for Young and Old Patients with Oral and Oropharyngeal Squamous Cell Carcinoma? A Systematic Review and Meta-Analysis.

Authors:  Swagatika Panda; Neeta Mohanty; Saurav Panda; Lora Mishra; Divya Gopinath; Alkananda Sahoo; Sumanth Kumbargere Nagraj; Barbara Lapinska
Journal:  Cancers (Basel)       Date:  2022-04-08       Impact factor: 6.575

7.  Prevention of Carcinogen-Induced Oral Cancer by Sulforaphane.

Authors:  Julie E Bauman; Yan Zang; Malabika Sen; Changyou Li; Lin Wang; Patricia A Egner; Jed W Fahey; Daniel P Normolle; Jennifer R Grandis; Thomas W Kensler; Daniel E Johnson
Journal:  Cancer Prev Res (Phila)       Date:  2016-06-23

8.  Gene targets of sulforaphane in head and neck squamous cell carcinoma.

Authors:  Lanlin Hu; Hua Li; Eliot D Lee; Jennifer R Grandis; Julie E Bauman; Daniel E Johnson
Journal:  Mol Med Rep       Date:  2019-10-23       Impact factor: 2.952

9.  Second cancers in patients with neuroendocrine tumors.

Authors:  Hui-Jen Tsai; Chun-Chieh Wu; Chia-Rung Tsai; Sheng-Fung Lin; Li-Tzong Chen; Jeffrey S Chang
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

10.  99mTc-3P-RGD2 molecular imaging targeting integrin αvβ3 in head and neck squamous cancer xenograft.

Authors:  Bing Yan; Fan Qiu; Ling Ren; Haojie Dai; Wei Fang; Haibo Zhu; Feng Wang
Journal:  J Radioanal Nucl Chem       Date:  2015-02-14       Impact factor: 1.371

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.